Why
so few conifer GMO in field tests?
Conifers
are important for commercial plantation forestry, e.g. in Sweden 99 per cent of
all forest tree seedlings raised are conifers. GMO (Genetic Modified Organisms,
GE) trees have become an important research target with the justification that
this would create better trees, either directly through GMO-forestry or
indirectly through a better basic understanding or supporting techniques (like
flowering induction). Why does not research put more attention on conifers
(even if that is more difficult), if the aim is applied rather than basic?
There is
a recent article about transgenic trees tested in North America (Silvae
Genetica 49:233-239). “Today only two field trials of transgenic trees have
been planted in Canada” (two poplar trials). In Table 1 (confined trials in US)
there are 3 conifers and 83 other tree species. I looked at
http://www.isb.vt.edu/cfdocs/fieldtests1.cfm
(which probably reflects the current situation) and found 15 pine and 1 spruce
trial. (So the conifers may be on way up, but the 15 pine trials seem all to be
the same species, institution and localisation.)
There is
information about GMO “field trials” (environmental releases) in the European
Union (EU) at
http://food.jrc.it/gmo/
This seems to include experiments with Scots pine and Norway spruce, but these
experiments are not field trials, just outdoor pollinations with transgenic
pollen. Thus where does not exist a single conifer field trial in the whole EU
(among 1649 GMO trials of which 17 were with trees).
Why has
the reluctance been so strong against establishing GMO trials with the most
important and relevant conifer species?
I submitted the
question above to FORESTGEN 010607 (that is the e-mail-discussion forum of the
worlds forest geneticists). This initiated a row of contributions to the
debate, which probably is the longest in the history of FORESTGEN (which,
however, does not say much as forest geneticists are not much for this form of debate)
and an additional discussion developed into comments to me, which was not
visible on FORESTGEN. However, most replies were concerned with issues only
slightly related to my question (why are there so few of the field trials with
conifers?). I made a general end-comment as follows to FORESTGEN
I
submitted the question “Why so few conifer GMO in field tests?” to FORESTGEN
June 6. Now I comment on the matter relating to the discussion that arouse and
in general.
GMO
is now successfully and without evident negative effects on environment or
human health used on more than 40 million hectare agricultural land (mainly US,
Canada and Argentine). This is after only two decades of development, which is
an extremely rapid implementation. Genetic engineering has a huge potential,
and where goes very large research investments into GMO related matters. The
technique must sooner or later spread to more countries, characters and crops.
Long
rotation conifers seem to be among the last potential targets for GMO, the need
of field evaluation is an important reason for that. The long rotation time can be seen as a good reason not to invest
in GMO for conifers (Friedman pointed out that longer rotation give less
incitements for investment in intensive forestry). But science should still
explore a potentially powerful practical option. Neither science explores the
potential to understand how genetics actually works in the forests if no field
trials are done.
It
may be wrong that long rotation conifers will come very late (if ever). After
accumulating some experience over rotation from short rotation conifers (e.g.
radiata on NZ, c.f. reply by Walter), it may be concluded that benefits evident
in tests over only a fraction of the rotation time (better establishment) are not
likely to be counteracted by disadvantages appearing late. But even if such a
decision probably will be found justified at some point in the future for some
types of GMO, this point lies probably many decades and more long term field
trials ahead.
We working
with long term forestry should not be too worried about the time perspective,
E.g. in Sweden investments in forest tree breeding started 1938 (in the never
realised hope of commercialising triploids). After more than six decades this
has lead to that more than half of the Swedish regeneration material originates
from first generation seed orchards. So the long rotation time should not
discourage scientists from getting started. But it seems to be in the World’s
interest to encourage and follow efforts on places, where the conifer rotation
time is shorter; and where conifer experiments are being established anyway
(see reply by Walter and http://www.ermanz.govt.nz/search/srch_reg.htm).
Both
public and private funds have enthusiastically supported research, which seemed
to bring GMO forests closer. This in combination with GMOs attractive features
for commercialisation (patents, “biotech”); the success in agriculture; and
brave visions by some scientists, may have created an over trust in a fast and
massive expansion of GMO into plantation forestry. But, at the same time,
plantation trials were rather rare and mainly comprised model systems. This
over trust in combination with strong emphases of characters in commercial
agriculture, which “people” often perceive as ecologically doubtful (herbicide
resistance and “home manufactured” pesticides), and its association to
commercial interests and mechanisms which are not familiar to the forestry sector,
have probably contributed to strong and premature demands from institutions
like “green certification” (cf. reply by Burley); WWF (cf. reply by Bisoffi);
and “Eco-terrorists” (cf. reply by Apedaile). Such “protests” also contribute
to the high costs of establishing field trials (cf. reply by Walter). There may
be reasons for a more relaxed attitude (cf contributions from Bisoffi, Walsh
and Frankis).
Not
tolerating GMO trees is a rather fresh decision in green certification, and I
do not think it is trustworthy that recent standards and principles should
exist there forever. There is much and frequent turbulence. A policy of never
tolerating a single GMO tree, while tolerating 50 million hectares of
agricultural equivalents, seems neither sustainable nor trustworthy (even if
different standards for forestry and agriculture is common on other issues,
think about fertilization, monoculture and herbicides etc.), especially when
GMO in a future will spread more to crops more similar to forest trees. Field tests
brings the GMO forest options closer in time, by making us more able to
evaluate advantages and risks. Perhaps it will also contribute to a more
relaxed attitude, if there exist a number of real GMO trees, which looks like
real trees. It seems in line with WWF demands (cf. reply by Bisoffi) to
establish field trials, as they are needed for risk-evaluation. Without field
tests, the true potential can never be evaluated.
Scientists
with GMO trials are justifiable worried for sabotage. Many GMO trials are not
replicated. Conventional forest field trials are almost always replicated, and
for Sweden I guess that the risk of “loosing” a site is something like 1/3. Why
not use replications more often for GMO trials? (That is not only because of the risk of sabotage.)
It
is technical difficult to make a conifer plant from a cell and GMO requires
changes in propagation technique which are difficult to master (cf. response by
Friedman). Conifer GMO trials seems actually to become more common (cf.
response by Mullin & Walter), perhaps reflecting improvements in
propagation techniques. That
“popular resistance” or high costs to an increasing degree prevent GMO field
trials does not seem reflected in the statistics. These factors are not likely
to hit harder against conifers than other tree species.
The
lack of GMO conifer field trials may reflect a trend that Forest Science
(Universities) does not trust in “genetic” field trials as a method to gain
knowledge nowadays. For our department (I am a University Professor) we have
responsibility for 107 active trials. All are with conifers. 79 were
established before 1990; 28 1990-1995; and no after 1996. For our department
the interest has certainly swung drastically towards “trial free non-conifer
GMOs”. The trend seems similar at University level (Swedish University of
Agricultural Sciences).
I was adviced an article in a past issue of
"Grain" (which is the
"Quarterly Newsletter of the Genetic Resources
Action International") titled "Can't See the Trees for the
Wood".
http://www.grain.org/publications/set001-en.cfm
Among different
official national GMO sites I found the NZ particular informative (they keep
much documentation available)
http://www.ermanz.govt.nz/search/srch_reg.htm
One article among
many:
The advantages and disadvantages of the application of genetic
engineering to forest trees: a discussion
J.H. Mathews, and M.M. Campbell.
pp. 371-380.
http://www3.oup.co.uk/foresj/hdb/Volume_73/Issue_04/